Shanghai, China - September 12, 2026 - On August 4, the 20th Frost & Sullivan Global Growth, Innovation and Leadership (GIL) ...

IMUNON partners with National Cancer Institute to advance IMNN-001 IL-12 immunotherapy beyond ovarian cancer. NCI assumes ...

Collaboration with NCI's Cancer Therapy Evaluation Program (CTEP) will evaluate IMNN-001in new indications and combination regimensIMUNON retains ...

The "DNA and Gene Cloning Services - Market Insights, Competitive Landscape, and Market Forecast - 2034" has been added to ResearchAndMarkets.com's offering. The global DNA and gene cloning services ...

Table 8.1: Examples of Viral Vectors Used in Gene Therapy Table 8.2: Plasmids Used in Gene Therapy Trials Figure 1: Global Viral Vector and Plasmid Manufacturing Market (by Region), 2019 and 2030 ...

Key opportunities include automated, closed and digitally monitored production; end-to-end CDMO services; viral vector capacity; scalable autologous and allogeneic platforms; regional manufacturing; ...

Through the collaboration, Genezen will offer access to 4basebio's synthetic DNA developed specifically for viral vector applications, creating a more streamlined path for cell and gene therapy ...

GenScript ProBio's new facility will be state-of-the-art, utilizing the latest technology and equipment in viral vector and plasmid manufacturing to scale up its production capacity and deliver end-to ...

We use the AdenoX Rapid Titer kit (Clontech now Takara Bio) for this service. This immunohistochemical assay involves making 3 serials dilutions of the virus and infecting 6 wells of a 24-well plate ...

Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035" report has been added to ...